Colin Minchom joins Hovione
Portuguese active pharmaceutical ingredient manufacturer Hovione has appointed Colin Minchom as vice president of its Particle Design Business Unit.
Minchom was most recently Patheon’s vice president of Pharmaceutical Development Services for North America. Based in East Windsor, New Jersey, he will report to Guy Villax, Hovione’s chief executive.
‘Dr Minchom is responsible for innovating Hovione’s Pharmaceutical Particle Design offerings to meet the development and commercial supply needs of the formulator with poorly bioavailable or otherwise challenging molecules,’ said Villax.
Minchom’s 29-year career includes extensive experience in the process, science and global regulation of drug development with emphasis on dosage forms and drug delivery.
Prior to the role at Patheon, Minchom was head of pharmaceutical sciences at Cerebrus, a privately held UK-based pharmaceutical company and has also worked for Eli Lilly and E R Squibb in formulation and product development, project management and product management.
Trained as a pharmacist at the Leicester School of Pharmacy in the UK, Minchom holds a PhD in Industrial Pharmacy from the University of Wales College of Cardiff.
Subscribe now to Cleanroom Technology to get unrestricted online access to our exclusive content and receive our high quality magazine every month.